Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate with Chemotherapy in Osteosarcoma
NCT01669369Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2013
- Primary completion
- Dec 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lithium carbonate in osteosarcoma (OS) (2 arms), sponsored by Sun Yat-sen University. Primary endpoints: Progression-Free Survival and Incidence of Chemotherapy-Induced Myelosuppression. Status: unknown.
02
Drugs
lithium carbonate
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT01669369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01669369.